標(biāo)題: Titlebook: Radiobiology of Glioblastoma; Recent Advances and Luigi Pirtoli,Giovanni Luca Gravina,Antonio Giorda Book 2016 Springer International Publ [打印本頁(yè)] 作者: cherub 時(shí)間: 2025-3-21 16:16
書(shū)目名稱Radiobiology of Glioblastoma影響因子(影響力)
書(shū)目名稱Radiobiology of Glioblastoma影響因子(影響力)學(xué)科排名
書(shū)目名稱Radiobiology of Glioblastoma網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Radiobiology of Glioblastoma網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Radiobiology of Glioblastoma被引頻次
書(shū)目名稱Radiobiology of Glioblastoma被引頻次學(xué)科排名
書(shū)目名稱Radiobiology of Glioblastoma年度引用
書(shū)目名稱Radiobiology of Glioblastoma年度引用學(xué)科排名
書(shū)目名稱Radiobiology of Glioblastoma讀者反饋
書(shū)目名稱Radiobiology of Glioblastoma讀者反饋學(xué)科排名
作者: 可以任性 時(shí)間: 2025-3-21 22:30 作者: 微不足道 時(shí)間: 2025-3-22 03:40 作者: Little 時(shí)間: 2025-3-22 05:04
Radiobiological Hints from Clinical StudiesAn overview of the clinical series assessing the efficacy of the most important targeted agents when used together with radiotherapy against glioblastoma is herein provided.作者: 輕浮思想 時(shí)間: 2025-3-22 11:16
Mathematical Modelling of Radiobiological ParametersAll treatment strategies are studied at the preclinical and clinical level, and the related endpoints are used to extract radiobiological parameters in mathematical models. This chapter aims to provide an overview of these approaches based on clinical and cellular data.作者: Exclude 時(shí)間: 2025-3-22 15:16
Luigi Pirtoli,Giovanni Luca Gravina,Antonio GiordaProvides the most recent and relevant advances in molecular radiobiology of glioblastoma, and the related possible changes in the clinical setting.Written by experts in the field.Bridges the gap of kn作者: MAG 時(shí)間: 2025-3-22 17:41 作者: 神秘 時(shí)間: 2025-3-22 22:33 作者: 蒼白 時(shí)間: 2025-3-23 05:26 作者: 舞蹈編排 時(shí)間: 2025-3-23 06:58
Luigi Pirtoli,Giovanni Luca Gravina,Antonio Giordanoovides readers with the state-of-the-art methods of multimodal emotion recognition, intention understanding, and application examples of emotional HRI systems.978-3-030-61579-6978-3-030-61577-2Series ISSN 1860-949X Series E-ISSN 1860-9503 作者: Constant 時(shí)間: 2025-3-23 11:03 作者: Infinitesimal 時(shí)間: 2025-3-23 14:49 作者: Visual-Acuity 時(shí)間: 2025-3-23 21:52
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options:756–84, 2012; Huse et al., Glia 59:1190–9, 2011). Approximately half of the newly diagnosed GBM patients have an extremely poor prognosis. Despite many successful achievements in different areas of oncology, prognosis of GBM has not changed over the past 30 years, except for a moderate benefit acqu作者: Desert 時(shí)間: 2025-3-24 00:38
Chemoradiotherapy: Radiation Total Dose and Fractionation genomics have significantly improved our knowledge of the molecular features of GBM, and this has translated into the identification of specific targets for potential treatments. Although the results are promising, the role of new strategies in the management of these patients remains to be defined作者: Diatribe 時(shí)間: 2025-3-24 04:28 作者: Confidential 時(shí)間: 2025-3-24 08:39
Clinical, Pathological, and Molecular Prognostic Parameters in Glioblastoma Patients Undergoing Chem prognosis through more and more sophisticated implementations, and evidence exists of an improvement of survival over the last decades, due also to recent imaging techniques. Outcome in clinical series presently reaches a bridgehead at a 12–15 months median survival, and 2- and 5-year overall survi作者: defeatist 時(shí)間: 2025-3-24 11:25 作者: BAIT 時(shí)間: 2025-3-24 17:38
Preclinical Models of Glioblastoma in Radiobiology: Evolving Protocols and Research Methodson molecularly targeted agents directed against certain components of intracellular signaling pathways involved in tumor growth and radioresistance..The current chapter discusses the preclinical models in GBM radiobiology. This chapter reviews the developments that allowed basic scientists and radia作者: 野蠻 時(shí)間: 2025-3-24 19:55 作者: 痛打 時(shí)間: 2025-3-25 03:08
Michela Buglione,Luca Triggiani,Paolo Borghetti,Sara Pedretti,Nadia Pasinetti,Stefano Maria Magrini作者: 元音 時(shí)間: 2025-3-25 06:07 作者: quiet-sleep 時(shí)間: 2025-3-25 10:40 作者: 冰河期 時(shí)間: 2025-3-25 13:27 作者: 松軟 時(shí)間: 2025-3-25 17:33 作者: habitat 時(shí)間: 2025-3-25 21:41
Francesca De Felice,Vincenzo Tombolini,Michela Buglione,Daniela Musio,Luca Triggiani,Stefano Maria M作者: Hangar 時(shí)間: 2025-3-26 03:40
Monica Mangoni,Mariangela Sottili,Chiara Gerini,Lorenzo Livi作者: CRANK 時(shí)間: 2025-3-26 08:09
Benjamin Cooper,Ralph Vatner,Encouse Golden,Joshua Silverman,Silvia Formenti作者: committed 時(shí)間: 2025-3-26 12:05
A. Cimini,A. Fidoamore,M. d’Angelo,A. Antonosante,L. Cristiano,E. Benedetti,Antonio Giordano作者: narcissism 時(shí)間: 2025-3-26 13:01 作者: 吞吞吐吐 時(shí)間: 2025-3-26 18:10
Marzia Toscano,Silvia Palumbo,Paolo Tini,Clelia Miracco,Giovanni Luca Gravina,Sergio Comincini作者: 令人發(fā)膩 時(shí)間: 2025-3-26 21:34 作者: d-limonene 時(shí)間: 2025-3-27 04:25
Anita Tandle,Uma Shankavaram,Cody Schlaff,Kevin Camphausen,Andra Krauze作者: –LOUS 時(shí)間: 2025-3-27 05:57 作者: 葡萄糖 時(shí)間: 2025-3-27 13:27 作者: Psychogenic 時(shí)間: 2025-3-27 15:12 作者: 倒轉(zhuǎn) 時(shí)間: 2025-3-27 21:07
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options the United States (CBTRUS), 2011). It can occur in all age groups, but it is prevalent in adults over 45 years of age (Central Brain Tumor Registry of the United States (CBTRUS), 2011). Among the several classification systems, the one supplied by World Health Organization (WHO) is the most widely 作者: 兇兆 時(shí)間: 2025-3-27 23:40 作者: Synapse 時(shí)間: 2025-3-28 04:55 作者: hypertension 時(shí)間: 2025-3-28 06:48 作者: 美色花錢(qián) 時(shí)間: 2025-3-28 11:04 作者: ALIAS 時(shí)間: 2025-3-28 15:45 作者: 太空 時(shí)間: 2025-3-28 22:30 作者: 檔案 時(shí)間: 2025-3-29 01:50
Genetic and Epigenetic Determinants in Tumor Initiation and Progression of Glioblastomagenesis. The recent genome-wide sequencing and large-scale epigenetic profiling studies have generated crucial new data into the interplay between genetic and epigenetic alterations in glioblastoma, leading to a better understanding of the genetics and epigenetics determinants in the different gliom作者: 現(xiàn)暈光 時(shí)間: 2025-3-29 05:35 作者: Glucocorticoids 時(shí)間: 2025-3-29 08:16
Cell Death Pathways, with Special Regard to Ionizing Radiation and Temozolomidemmed cell death (PCD) in mammalian tissues. Resistance to apoptosis was closely linked to tumorigenesis, and has taken a central position in cell death research. However, in the last years it has become evident that radiotherapy as well as other therapeutic agents, including temozolomide (TMZ) are a作者: 謙虛的人 時(shí)間: 2025-3-29 14:41
miRNA Manipulation in Modifying Radiation Sensitivity in Glioblastoma Models are also endogenous molecular weapons of the tumor cells to respond to therapy: in human glioblastoma multiforme (GBM) cells miRNA can counteract the radiation effects interfering with signal transduction cascaded or controlling the fate of the cell by the regulation of programmed cell death proces作者: mettlesome 時(shí)間: 2025-3-29 17:00 作者: BILK 時(shí)間: 2025-3-29 21:56 作者: 生來(lái) 時(shí)間: 2025-3-30 00:37
2197-781X etting.Written by experts in the field.Bridges the gap of kn.This text properly considers the most recent and relevant advances in molecular RB of GB, taking into account the related topics of pathobiology, and underscores the most promising translational perspectives from the preclinical to the cli作者: Basal-Ganglia 時(shí)間: 2025-3-30 05:06
miRNA Manipulation in Modifying Radiation Sensitivity in Glioblastoma Modelsproach to favorably interfere within the altered gene network of human brain tumors..In this review, we highlight the state of the art of the capacity of miRNA to modulate the behavior of glioblastoma cells to ionizing radiation preclinical schemes.作者: 大酒杯 時(shí)間: 2025-3-30 11:15 作者: Fecal-Impaction 時(shí)間: 2025-3-30 12:54 作者: Inscrutable 時(shí)間: 2025-3-30 17:46
Tumor Microenvironment, Hypoxia, and Stem Cell-Related Radiation Resistancetter knowledge of microenvironment biology could help to develop new targeted therapies able to sensitize glioblastoma to radiation, in order to overcome treatment resistance, and would be useful also for the optimization of radiotherapy treatment planning.作者: milligram 時(shí)間: 2025-3-30 21:27
Cell Death Pathways, with Special Regard to Ionizing Radiation and Temozolomidewill review currently known mechanisms of both IR and TMZ in inducing cell death, the possibility to modulate PCD as well as other approaches which will open new perspectives for improving the efficacy of therapy in GB.作者: 尊重 時(shí)間: 2025-3-31 03:00
NanoMaterials Technology for Research Radiobiologynd imaging, highlighting the emerging possibilities of theranostic nanomedicines in cancer cure. The current NMs platforms for future clinical application with regard to imaging and treatment of glioblastoma, one of the most deadly diseases characterized by high resistance to chemotherapy and radiotherapy, will be discussed.作者: 圓桶 時(shí)間: 2025-3-31 08:53 作者: 光滑 時(shí)間: 2025-3-31 09:12
Broadening Wastewater Monitoring of SARS-CoV-2 RNA, of size and infrastructure and provides examples of communities, universities, and businesses in monitoring efforts. It also introduces several joint ventures between government, university, and community. It outlines the challenges of broadening participation in underdeveloped or fragmentary infrastructure settings.作者: 來(lái)這真柔軟 時(shí)間: 2025-3-31 17:19
